Related by context. All words. (Click for frequent words.) 69 stated Michelle Berrey 66 Dr. Whitcup 66 Initiates Clinical 66 Ulrich Dauer CEO 65 Iris Loew Friedrich 65 Officer Charlotte Keywood 65 Emil Kakkis MD Ph.D. 64 Mohammad Azab MD 64 Submits Response 64 Begins Dosing 64 James Jiayuan Tong 63 Eric L. Dobmeier 63 Armando Anido Chief Executive 63 Initiates Clinical Trial 63 James Sapirstein 63 Martin Nicklasson CEO 63 Jean Pierre Lehner 63 Philippe Archinard Chief Executive 62 Nancy Simonian MD 62 Initiates Enrollment 62 Nonclinical 62 Dr. Jaap Goudsmit 62 Dr. Fahar Merchant 62 Loïc Maurel MD 62 Initiate Clinical Trial 62 Safi Bahcall Ph.D. 62 Immunotherapeutic 62 Meets Primary Endpoint 62 HDL Selective Delipidation 62 Eric Rowinsky MD 61 dual endothelin receptor antagonist 61 ImmunoCellular Therapeutics 61 André Michel Ballester 61 Logical Therapeutics 61 recurrent herpes labialis 61 Alton Boynton 61 anti infective treatments 61 Mihael Polymeropoulos MD 61 Potent Antiviral Activity 61 Pedro Lichtinger 61 Thiovir 61 J. Donald deBethizy 61 Phase 2b Clinical Trial 61 Steve Cartt Executive 61 Announces Poster Presentations 61 Aviptadil 61 Dr. Bruno Giannetti 61 SNT-MC#/idebenone 61 Liprotamase 61 Fondaparinux 61 Per Olof Wallström 61 Reports Preclinical Data 61 adalimumab Humira 61 Presents Preclinical Data 61 Michel Morre DVM 61 Kirsten Drejer 61 Vicriviroc 61 Dr. Karl Mettinger 61 Wellstat 60 Mark Pykett 60 Phase 2a Trial 60 Fabry Disease 60 Eliseo Salinas 60 Georges Gemayel 60 Barry D. Quart 60 Needham Biotechnology 60 Preclinical Models 60 James Manuso 60 Receives Orphan Drug Designation 60 eritoran 60 Paul Laikind 60 lucinactant 60 Antisense Pharma 60 Igor Gonda 60 Camillo Ricordi MD 60 Howard H. Pien 60 Robert L. Bratzler 60 Potelligent Technology 60 Anthony Giovinazzo 60 Sudhir Agrawal D.Phil 60 Metabolic Disease 60 Renal Cancer 60 Mark A. Sirgo 60 thetreatment 60 Personalized Immunotherapy 60 Dr. Arndt Schottelius 60 Intravenous Formulation 60 Cardiovascular Therapeutics 60 Nicholas Borys 60 Aflibercept 60 Neil K. Warma 60 Altastaph 60 Investigational Treatment 60 Zami Aberman Chairman 60 Preclinical Development 60 Hematological Malignancies 60 thalidomide Thalomid 60 p# inhibitor 60 intranasal formulation 60 Gets FDA Clearance 60 Perforomist ™ Inhalation Solution 60 Submits IND 60 Hugues de Bantel 60 Lixivaptan 60 Philippe Calais 60 Hoyoung Huh 60 Drug Formulation 60 acetonide FA 60 midstage clinical 59 Maribavir 59 ACOMPLIA R 59 Daniel Junius 59 Dr. Flemming Ornskov 59 JAK2 Inhibitor 59 Mycophenolate Mofetil 59 Dr. Aiping Young 59 Pulmonary Arterial Hypertension 59 Dr. Elliot Ehrich 59 Percutaneous Tibial Nerve Stimulation 59 immune globulin intravenous 59 Christopher J. Schaber 59 SMT C# 59 Initiates Phase III 59 June Almenoff MD 59 immuno modulatory 59 inhaled AAT 59 beta 1a 59 Dr. Hassan Salari 59 BIM #A# 59 Noxafil 59 Harry Palmin President 59 Steven R. Deitcher 59 NAVISTAR R 59 Christian Itin 59 Pemphigus 59 Daniel Vasella Chairman 59 Diastolic Heart Failure 59 IV Busulfex 59 Ron Bentsur 59 Nicole Onetto MD 59 carbapenem antibiotic 59 Telbivudine 59 Vojo Vukovic MD Ph.D. 59 OHR/AVR# 59 Dual Antiplatelet Therapy 59 Damian Marron 59 Juergen Engel Ph.D. 59 Alvine Pharmaceuticals 59 Adrian Hobden Ph.D. 59 Aegerion Pharmaceuticals 59 Anticancer Drug 59 CAMPATH 59 EVIZON TM 59 adenosine A2A 59 Dr. Randall Yatscoff 59 Gearoid Faherty Chief Executive 59 Carl A. Pelzel 59 HCV Protease Inhibitor 59 Dr Bernd Hentsch 59 FDA Approvals 59 immunotherapeutic vaccine 59 Elisabeth Lindner CEO 59 Late Breaker 59 Fluconazole 59 Zeb Horowitz 59 mertansine 59 Acute Renal Failure 59 Cellular Therapies 59 CRMD# 59 Michael H. Tardugno 59 ChronVac C R 59 Anti Infective 59 Quay MD Ph.D. 59 essential thrombocythemia ET 58 Demonstrates Efficacy 58 Novel Therapeutic 58 cMET 58 Transdermal Delivery 58 Michael V. Novinski 58 Hematological 58 ICAAC IDSA 58 Dino Dina 58 RhuDex ® 58 Hedgehog antagonist 58 vidofludimus 58 Achieves Primary Endpoint 58 HQK 58 4SC commented 58 Clinical Trial Data 58 Oncolytic 58 Monoclonal antibody 58 Donald L. Drakeman 58 Novel Small Molecule 58 Kinase Inhibitors 58 stated Belinda Tsao 58 Cx# [002] 58 Peripheral Arterial 58 Dr. Anil Diwan 58 Muraglitazar 58 ORENCIA R 58 fosbretabulin 58 Factor VIIa 58 Successfully Completes Phase 58 Spiro Rombotis President 58 aerosolized surfactant 58 administered intramuscularly 58 Elliott Sigal 58 Frozen Shoulder syndrome 58 Kinase Inhibitor 58 Inflammatory Diseases 58 ARIXTRA R 58 Vaccine Immunology 58 clevidipine 58 Presents Preclinical 58 Files IND 58 Stanate R 58 Ron Bentsur Chief Executive 58 Proquin XR 58 Ph.D. Targacept 58 BAL# [002] 58 Inhalation Solution 58 AFREZZA TM 58 Carl Spana 58 Civacir 58 Hsp# Inhibitor 58 Diabetic Foot Ulcer 58 NeuroVax 58 humanized monoclonal 58 Intravail ® 58 Shows Promise Against 58 Orqis Medical 58 ThromboGenics commented 58 Nitazoxanide 58 Æterna Zentaris 58 DepoCyt 58 Matthias L. Wolfgruber 58 Jean Francois Rossignol 58 Antiarrhythmic 58 InNexus Biotechnology 58 Clinical Trial Results 58 Nicholas Nicolaides 58 RNAi Therapeutic 58 MOVIPREP R 58 Kevin Rakin 58 Photodynamic 58 itraconazole Sporanox 58 Joshua Boger Ph.D. 58 immuno therapeutic 58 Entry Inhibitor 58 RECOTHROM R 58 DermTech International 58 t2cure GmbH 58 virus HCV 58 Armando Anido 58 Oncologic 58 SPRYCEL ® 58 abacavir Ziagen 58 Initiates Phase II 58 Schizophrenia Treatment 58 Shows Efficacy 58 Manja Bouman CEO 58 Dr. Wayne Danter 58 Urology Gynecology 58 Elocalcitol 57 Technosphere ® 57 Omacetaxine 57 inhalation powder 57 Alvesco R 57 NicOx commented 57 Amgen Neulasta ® 57 Kemal Malik 57 G#DT 57 Dr. Wolfgang Wein 57 Patrice Milos 57 Romark 57 MyVax ® 57 Kamada AAT 57 John R. Plachetka 57 FDA APPROVES 57 Present Preclinical Data 57 Lonnie Moulder 57 Refractory Angina 57 PDE# inhibitors 57 Intradermal 57 VitiGam 57 Alinia 57 Rik J Deitsch 57 Sol J. Barer 57 reslizumab 57 Progressive Multifocal Leukoencephalopathy 57 Anidulafungin 57 Vaughn M. Kailian 57 Prolongs Survival 57 Quark Pharmaceuticals 57 Dosage Form 57 Werner Cautreels 57 nucleotide analog 57 BioNumerik 57 DDP# 57 Alferon N 57 Drew Fromkin President 57 Antisense Pharma GmbH 57 photodisinfection 57 Pegloticase 57 Ecallantide 57 Phase IIb Clinical Trial 57 Hedgehog Pathway Inhibitor 57 Metabolic Endocrinology 57 IND Application 57 Anthony J. Armini 57 Neogenix 57 Dr. Steve Pakola 57 Investigational Oral 57 Phase #b/#a clinical 57 Lung Rx 57 Cethromycin 57 Preclinical Data 57 UPLYSO 57 KaloBios 57 Hepatitis C Virus 57 forodesine 57 Asthma COPD 57 Onconase 57 Yaffa Beck 57 commented Alexis Borisy 57 Metabolic Disorders 57 Daniel Tasse 57 Ed Quilty 57 Myelodysplastic Syndromes 57 Tezampanel 57 Dr. Ihor Gussak 57 Dr Andreas Hohlbaum 57 non nucleoside inhibitor 57 Pivotal Clinical Trial 57 Enhanze 57 Moxifloxacin 57 Hans Joachim Lohrisch 57 Presents Positive 57 novel therapeutic antibodies 57 Lorianne Masuoka MD 57 BrachySil TM 57 Minimally Invasive Surgical 57 orally inhaled migraine 57 Eraxis 57 treat chronic sinusitis 57 DMD DMSc 57 Migranal 57 Wolfgang Renner 57 Patrik De Haes 57 Cancidas 57 Falk Pharma 57 DEY LP 57 J. Melamede 57 Pharmacokinetics PK 57 Dan Passeri Curis 57 Diabetic Macular Edema 57 Ira L. Goldknopf 57 OMNARIS HFA 57 Silodosin 57 molecular diagnostic assay 57 Yuichi Iwaki MD Ph.D. 57 SinuNase ™ 57 Tigecycline 57 Pancreas Cancer Vaccine 57 Neugene 57 Cellular Immunology 57 Steven B. Ratoff 57 AERx iDMS 57 Klaus Schollmeier Chief Executive 57 Avtar Dhillon MD 57 Prostate Cancer Vaccine 57 Therapeutic Antibody 57 Submits NDA 57 Ralph Makar 57 Flemming Ornskov 57 Zeldox 57 Drug Candidate 57 Cardiometabolic 57 Nipent R 57 Procyon Biopharma 57 Anat Cohen Dayag 57 Eric von Hofe 56 Ronald Brus 56 EP #R 56 Respiratory Virus 56 Ampakine 56 Zemiva TM 56 Cytotoxic 56 lumiliximab 56 Michael Fonstein 56 Dose Ranging Study 56 demonstrated antitumor activity 56 Kathy Ordoñez Chief Executive 56 vapreotide acetate 56 Synergy Pharmaceuticals 56 M.D. Ph.D. 56 Treating Chronic 56 volociximab 56 Pimavanserin 56 Tovaxin TM 56 Optimata 56 Michele Garufi Chairman 56 NP2 Enkephalin 56 HCl Tablets 56 Psoriasis Drug 56 Adjuvanted 56 Camvia 56 proprietary radiolabeled monoclonal 56 Replacement Therapy 56 Harold H. Shlevin 56 Kepivance 56 Cardio vascular 56 Novel Therapies 56 JenaValve 56 Nebulized 56 Emisphere Technologies 56 Advanced Melanoma 56 PHX# 56 dexanabinol 56 Dr. Philip Toleikis 56 Anna Gluskin Generex 56 Antifungal 56 Aegera 56 Patients Treated With 56 PharmD Ardea 56 Christoph Westphal MD Ph.D. 56 GW# [003] 56 oral salmon calcitonin 56 molecular imaging radiopharmaceutical 56 Veregen TM 56 Female Urology 56 ChronVac C 56 Evoltra ® 56 Itraconazole 56 toenail onychomycosis 56 Reduces Mortality 56 apricitabine 56 Hematologic Oncology 56 Metabolic Disorder 56 commented Nicholas Landekic 56 Dr. Avtar Dhillon 56 Prophylactic Treatment 56 Genentech Rituxan 56 ATL/TV# 56 Lauriad ® 56 Martin Nicklasson 56 II Clinical Trial 56 GRN# 56 administered intranasally 56 radezolid 56 selective S#P# receptor agonist 56 Hormone Refractory Prostate Cancer 56 herpetic keratitis 56 Mr. Fater 56 Dalbavancin 56 FDA Approvable Letter 56 Adjunctive 56 Clinical Decision Making 56 ERYtech 56 Inflammatory Arthritis 56 Elestrin TM 56 cytomegalovirus retinitis 56 Nancy Wysenski 56 Inhaled Liposomal Ciprofloxacin 56 AFFiRiS 56 AFRS TM 56 Affimed Therapeutics AG 56 Amgen Neulasta R 56 CCR9 antagonist 56 ORENCIA ® 56 Crixivan 56 HEPLISAV TM 56 Homi Shamir 56 Tyzeka Sebivo 56 NanoPass 56 VANOS TM 56 Serdolect ® 56 Richard Azani 56 Oasmia 56 Mr. Frank Menzler 56 Marillion Pharmaceuticals 56 Tod Woolf Ph.D. 56 Mr. Pierre Laurin 56 methylnaltrexone bromide 56 Etubics 56 Rotavirus Vaccine 56 NS#/#A protease 56 Teriparatide 56 Ophthalmics 56 Anti Tumor 56 Dendritic Cells 56 Vitrasert R 56 Long Term Efficacy 56 NeuroAid TM 56 Carlo Montagner 56 Nicotine Vaccine 56 Dr. Henrich Guntermann 56 AZILECT ® 56 Mark HN Corrigan 56 John Langstaff Cangene 56 Oral Fingolimod 56 Multaq dronedarone 56 Macrolide 56 hyaluronidase enzyme 56 successfully commercialize Iluvien 56 INS# [002] 56 Hepatocellular Carcinoma 56 Yves Rosconi 56 ImmuKnow R 56 oral prodrug 56 DepoDur 56 Bucindolol 56 Prolastin R 56 Inovio Pharmaceuticals 56 Levitt MD Ph.D. 56 polycythemia vera essential thrombocythemia 56 pioglitazone hydrochloride 56 etanercept Enbrel 56 denileukin diftitox 56 Demonstrates Sustained 56 Immunex Corporation 56 Guanilib 56 SNT MC# 56 Anti infective 56 GSK Oncology 56 Non Invasive Treatment 56 Initiates Phase 2b 56 oral beclomethasone dipropionate 56 Therapeutic Competitors Companies 56 Cytometry 56 Onno van de Stolpe 56 Dr. Sosne 56 Supernus Pharmaceuticals 56 Patient Enrollment 56 Clinical Dermatology 56 stated Dominique Costantini 56 AMPA kainate 56 Bacteremia 56 Postdoctoral Position 56 Vitaxin 56 Xolegel 56 Joe Feczko 56 Rosty Raykov Chief Executive 56 Pedro Lichtinger Optimer 56 Acute Heart Failure 56 levocetirizine 56 Receives Approvable Letter 56 Cerus Corporation 56 Retacrit 56 Shai N. Gozani 56 Surfaxin LS 56 recombinant FVIII 55 Phase IIA 55 Ludwin Monz 55 Xcytrin R 55 Lupus Nephritis 55 Darusentan 55 Mucosal 55 Bendamustine 55 SPRIX ® 55 ERYtech Pharma 55 novel immunotherapeutic 55 Exosome 55 Jing Lou 55 Oral Insulin Capsule 55 PEG IFN 55 Tuan Ha Ngoc 55 Fluticasone 55 Dr. Isa Odidi 55 See CLINICAL PHARMACOLOGY 55 Humanetics 55 Squalamine 55 THALOMID 55 cannabinor 55 Triapine R 55 Ms. Katen 55 Virologic 55 Dr. Marlies Sproll 55 Jens Schneider Mergener 55 Virtual Histology 55 Targeted Therapies 55 Jeffrey M. Ostrove 55 Cardio Vascular 55 Acute Ischemic Stroke 55 SUTENT ® 55 glucokinase activator 55 Tracleer ® bosentan 55 Sanvar R 55 Dr. Ayalew Tefferi 55 Dr. Bernhard Sixt 55 Vimpat ® lacosamide 55 MAGE A3 ASCI 55 Kiadis Pharma 55 Cordis Endovascular 55 pharmacokinetic PK study 55 Files Investigational 55 Multimeric 55 QVAR 55 Alexis Borisy President 55 Initiate Phase 55 miconazole Lauriad ® 55 aripiprazole Abilify 55 Musculoskeletal Diseases 55 Trofex 55 Panzem R 55 gets USFDA nod 55 Robert L. Chioini 55 ACAPODENE TM 55 Bill Forbes Pharm.D 55 Rolland Yves Mauvernay 55 NV1FGF 55 Charlotte Keywood 55 Gamunex C 55 Pivotal Study 55 VIRxSYS 55 Antiviral Therapy 55 nasal spray formulation 55 Anticoagulant 55 Bioequivalence 55 Nicholas Landekic 55 Demonstrates Positive 55 CMV vaccine 55 Phase III ADT 55 Disease Modifying 55 SYN# 55 OMNARIS AQ 55 Phase 2a preventative 55 Phase III Clinical Trial 55 FDA Clears 55 Successfully Treats 55 nosocomial pneumonia 55 FOLOTYN ® 55 HealthSonix 55 Auxilium Pharma 55 Hematologic 55 Immunologic 55 Cinryze ™ 55 Staphylococcal 55 Telzir 55 Dan Passeri 55 oxymorphone ER 55 Freedom Meditech 55 telaprevir VX 55 Announces FDA Clearance 55 Inflammatory Disease 55 Clindamycin 55 Phase Ib Clinical Trial 55 Transcatheter 55 Steven A. Kriegsman 55 systemic RNAi therapeutic 55 Pivotal Phase III 55 EnVivo 55 Arthur S. Przybyl 55 DermaVir 55 MetroGel 55 IND Filing 55 Lymphoid 55 ASCO GU 55 Acute Pain 55 Begins Clinical Trial 55 lexidronam injection 55 Zirgan 55 Bicalutamide 55 GVAX ® 55 Investigational Compound 55 MultiCell Technologies 55 Biomarker Study 55 Overactive Bladder 55 Therapeutic Competitors Report 55 TapImmune 55 TransVax TM 55 Embolic Protection 55 Intravitreal 55 valacyclovir Valtrex 55 AMITIZA ® 55 HCV polymerase 55 Per Olof Andersson 55 Psychologist Clinical 55 Treatment Shows Promise 55 piperacillin tazobactam 55 Myolimus 55 Maven Semantic 55 Molecular Diagnostic 55 Arpida Ltd. 55 Systemic Lupus Erythematosus SLE 55 Mycamine 55 Successfully Treated 55 sodium stibogluconate 55 Roch Doliveux Chief Executive 55 Saquinavir 55 ThromboGenics commenting 55 BiondVax 55 Medizinische 55 Jeffrey Adelglass MD FACS 55 TASKi2 55 Harold Van Wart 55 Bisphosphonate 55 CONBRIZA 55 Viralytics 55 Onko Sure TM 55 nasally delivered 55 TOPAMAX R 55 VivaGel TM 55 Kazumi Shiosaki 55 FACTIVE ® 55 eligen 55 HepaLife Technologies Inc. 55 resistant Staphylococcus aureus MRSA 55 Linezolid 55 PROCHYMAL 55 Cumulase 55 Dr. McHutchison 55 riociguat 55 Acute MI 55 Don Kiepert President 55 Pseudomonas aeruginosa infections 55 includes Dideco CarboMedics 55 OTCBB CGXP 55 IIa Clinical Trial 55 Ludo Reynders 55 urethral bulking agent 55 Vitro Activity 55 nalbuphine ER 55 sitagliptin metformin 55 hypereosinophilic syndrome 55 Anders Ekblom 55 patientswith 55 Telithromycin 55 SYCREST 55 eniluracil 55 Francois Nader 55 Dr. Halvor Jaeger 55 RNA antagonists 55 epoetin zeta 55 Senetek PLC 55 Kevetrin TM 55 Saizen R 55 pexiganan 55 RhuDex 55 Biphasic 55 Rosen ViroPharma 55 Bassil Dahiyat Ph.D. 55 selective modulator 55 AEMD 55 CTAP# Capsules 55 virosome 55 oropharyngeal candidiasis 55 Symadex 55 hereditary emphysema 55 WILEX AG 55 Interferon Beta 55 Miacalcin 55 David Sidransky 55 QLT# 55 DURIN TM 55 Abbokinase 55 AJ Kazimi Chief Executive 55 Oncology Merck Serono 55 CA9 SCAN 55 Frank Verwiel MD 55 Dual Opioid TM 55 Amir Avniel 55 phase III isavuconazole 55 Photodynamic Therapy 55 Tobira Therapeutics 55 Evoltra TM 55 AA Amyloidosis 55 PEGylated Fab fragment 55 Revotar 55 Cellegy Pharmaceuticals 55 AVEO Pharmaceuticals 55 Budesonide 54 Albugon 54 clonidine hydrochloride 54 Novelos Therapeutics 54 Menelas Pangalos 54 David H. Fater 54 therapeutic monoclonal antibody 54 Therapeutic Competitors companiesandmarkets.com adEgemonye 54 Cardiotoxicity 54 ergot derivatives 54 Therinject 54 Interferon beta 1a 54 Duane DeSisto 54 Dr. Allan Mandelzys 54 Gemzar gemcitabine 54 Pulse Oximetry 54 daptomycin 54 TRANSDUR Bupivacaine 54 Patient Treated 54 Vascugel 54 topically administered 54 Kauffman MD Ph.D. 54 Dr. Kobi Vortman 54 David E. Kandzari 54 Dr. Damaj 54 Viramidine 54 ASCO GI 54 Friedhelm Blobel 54 apomorphine hydrochloride 54 Gelclair 54 Sanctura XR 54 Clinical Efficacy 54 Obecure 54 budesonide foam 54 Bosutinib 54 PEG SN# 54 Bernd Seizinger 54 PSMA ADC 54 investigational oral hepatitis C 54 Virulizin ® 54 Surgical Mesh 54 huC# DM4 54 humanised monoclonal antibody 54 Tocosol Paclitaxel 54 Mary Tagliaferri 54 Neoplasms 54 investigational antibiotic 54 Fereydoun Firouz 54 Intranasal 54 Phase Ib II 54 Phase Ib study 54 SIR Spheres 54 Myoblast 54 Capsulution 54 Caroline Loewy 54 Nasdaq IDIX 54 Mirapexin 54 metastatic malignant 54 Geert Kersten Chief Executive 54 OvaRex R 54 John F. Thero 54 ANN INTERN MED 54 Ganciclovir 54 Tikvah Therapeutics 54 Insulin Nasal Spray 54 INOmax R 54 Tracleer r 54 HuCAL antibodies 54 Mechanical Circulatory Support 54 EOquin R 54 Fosphenytoin 54 cellular immunotherapy 54 Evoltra 54 COPD inhalation anthrax 54 Panzem R NCD 54 immatics 54 Dose Escalation 54 plasma kallikrein inhibitor 54 Phase IIIB IV 54 Interferon Gamma 54 Injury ALI 54 Significantly Improves 54 Daclizumab 54 DiaKine Therapeutics 54 Biliary System 54 Andrew Uprichard 54 Lenocta TM 54 ThGRF 54 Emer Leahy 54 Microalbuminuria 54 Didanosine 54 orally administered inhibitor 54 PREVENAR 54 ospemifene 54 Recombinant Human 54 David Aviezer 54 Dr. Nabil Dib 54 Microsphere 54 YONDELIS 54 ATL# [002] 54 cytomegalovirus immune globulin 54 hyperphenylalaninemia HPA due 54 TheraCIM h R3 54 enoxaparin Lovenox 54 Clinical Outcome 54 Clinical Trial Evaluating 54 Burkhard Phone 54 Steven Kriegsman 54 Cardiovascular Metabolic 54 immunotherapy treatments 54 Demonstrate Significant 54 Peginterferon alfa 2b 54 Adrian Hobden 54 Carbamazepine 54 IMA# 54 TRO# 54 Alan Kessman Chief Executive 54 Japanese Encephalitis vaccine 54 Drug Shows Promise 54 Mr. Armando Anido 54 levoleucovorin 54 Michael Onuscheck 54 Oracea ® 54 Entocort 54 TM Aganocide 54 Dr. Joerg Reinhardt 54 Saegis Pharmaceuticals 54 Orapred ODT 54 Darinaparsin 54 PROSTASCINT R 54 Arno Therapeutics 54 Chang Ahn Rexahn 54 Gregory A. Demopulos 54 Anavex #-# 54 incyclinide 54 Auto Injector 54 Diagnostic Tests 54 Increlex ® 54 BIOSAFE 54 REGiMMUNE 54 Eric Bjerkholt 54 Edward Lanphier Sangamo 54 potent cytotoxic 54 noninfectious uveitis 54 ularitide 54 Entecavir 54 nephropathic cystinosis 54 R Saizen R 54 Timo Veromaa 54 Aneurysm Repair 54 Errol De Souza 54 Glatiramer acetate 54 Nasdaq NPSP 54 Clinical Guideline 54 Somatuline 54 ASX PGL 54 Tina Sampalis 54 Pieter Muntendam 54 Tony Milici 54 Bioral ® 54 External Beam 54 BARACLUDE R 54 JJ Finkelstein 54 Valtropin 54 faropenem medoxomil 54 HuMax CD4 54 Thomas P. Koestler 54 Immune Mediated 54 Spirus Medical 54 EnzymeRx 54 BioSante Pharmaceuticals NASDAQ BPAX 54 Transdermal Patch 54 Jean Jacques Garaud 54 Vidaza azacitidine 54 #:#-# [031] 54 pleconaril 54 targeted radiotherapeutic 54 Ryuji Ueno 54 Gil Allon Chief Executive 54 Glenn A. Oclassen 54 Metastatic Cancer 54 Muscle Wasting 54 IlluminOss 54 brivaracetam 54 SEPET TM 54 NovaBay Pharmaceuticals 54 Aliskiren 54 Anker MD Ph.D. 54 parenterally administered 54 Tragara Pharmaceuticals Inc. 54 histone deacetylase HDAC inhibitor 54 Nanobiotix 54 vinorelbine tartrate 54 orally inhaled 54 Indomethacin 54 nonhuman primate model 54 Hypercholesterolemia 54 Image Guided 54 CRLX# 54 Referenced EEG 54 NYSE Amex AEN 54 SafeStitch Medical 54 Naglazyme R 54 Cardioxyl 54 Gregory D. Casciaro 54 Oropharyngeal Candidiasis 54 Mitchel Sayare 54 Plaque Psoriasis 54 DUROS 54 Sustiva efavirenz 54 Catherine M. Burzik 54 CytoFabTM 54 TransVax tm 54 eFlow R 54 Ulrich Grau Ph.D. 54 Rifampicin 54 linezolid resistant 54 Hakan Edstrom 54 Phase IIb Trial 54 ß blockers 54 Ralivia TM 54 Myocet 54 Garth Likes 54 budesonide inhalation suspension 54 Andy Boorn 54 Circulatory Support 54 Tumor Response 54 nasal formulation